HRS-5765
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HRS-5765, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of HRS-5765 in Healthy Participants [Phase 1]